References

1. Diagnosis and control of epilepsy in the cat. Rusbridge, C. s.l. : British Veterinary Association, 2005, In Practice, Vol. 27, pp. 208-214.

2. Rusbridge, C. Feline Orofacial Pain Syndrome: Face and tongue mutilation syndrome in Burmese cats. s.l., United Kingdom : Claire Rusbridge, May 2008.

3. EFNS guidelines on pharmacologic treatment of neuropathic pain. Attal, N, et al. 2006, European Journal of Neurology, Vol. 13 (11), pp. 1153-169.

4. Bagley, R.S. Fundamentals of Veterinary Clinical Neurology. s.l. : Blackwell Publishing, 2005. pp. 14-15.

5. Trigeminal neuralgia - pathophysiology, diagnosis and current treatment. Nurmikko, T.J and Eldridge, P.R. 2001, British Journal of Anaesthesia, Vol. 87, pp. 117-32.

6. Rosner, H and Diwan, S. The role of gabapentin in the management of neuropathic pain. [ed.] Munglani R, Schmidt W.K Bountra C. Pain: current understanding, emerging therapies and novel approaches to drug discovery. s.l. : Marcel Dekker, 2003, pp. 781-787.

7. Boivie, J. Central pain. [book auth.] PD Wall and Melzack R. [ed.] PD Wall and R Melzack. Textbook of pain. 4th Edition. s.l. : Harcourt Publishers Limited 1999, 1999, pp. 879-911.

8. Supressive effects of oxcarbazepine on tooth pulp-evoked potentials recorded at the trigeminal spinal tract nucleus in cats. Kiguchi, S, Ichikawa, K and Kojima, M. 2001, Clinical and Experimental Pharmacology and Physiology, Vol. 28, pp. 169-175.

9. Treatment of facial pain with gabapentin: case reports. Schachter, S.C and Carrazana, E.J. 3, May-June 1997, Journal of Epilepsy, Vol. 10, pp. 148-150.

10. Plumb, D.C. Plumb's Veterinary Drug Handbook. 4th Edition. s.l. : Pharma Vet Inc., 2005. pp. 51-52.

11. Landsberg, G.M, Hunthausen, W.L and Ackerman, L. Handbook of behavious problems in the dog and cat. s.l. : Elsevier Health Sciences, 2003. pp. 189-190.